BioCryst Pharmaceuticals

BioCryst Pharmaceuticals is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan and autoimmune diseases as well as antiviral drugs. Its most advanced candidate drug is the antiviral Peramivir, which has been approved in Japan, South Korea, and China.